Exploration of Medicine (Apr 2024)

Physiologically driven nanodrug delivery system for targeted lung cancer treatment

  • Shiying Zhang,
  • Xia Li,
  • Yang Liu,
  • Hui Li,
  • Zhiyue Zhang

DOI
https://doi.org/10.37349/emed.2024.00221
Journal volume & issue
Vol. 5, no. 2
pp. 280 – 311

Abstract

Read online

Lung cancer remains a leading cause of cancer-related deaths globally, and a significant number of patients are ineligible for surgery, while chemoradiotherapy often shows limited efficacy, a systemic distribution, a low drug concentration at tumor sites, severe side effects, and the emergence of drug resistance. In this context, a nanodrug delivery system (NDDS) has emerged as a promising approach for lung cancer treatment, offering distinct advantages such as targeted delivery, responsiveness to the tumor microenvironment, site-specific release, and enhanced induction of apoptosis in cancer cells, ultimately leading to tumor growth inhibition or even elimination. This review aims to provide an overview of the physiological characteristics of lung cancer, highlight the limitations of conventional treatment methods, and extensively examine recent significant advancements in NDDS utilized for lung cancer therapy. The findings from this review lay the foundation for further development and optimization of NDDSs in the treatment of lung cancer.

Keywords